US20200330323A1

US20200330323A1 - Vibratory Nerve Exciter

Info

Publication number: US20200330323A1
Application number: US16/853,477
Authority: US
Inventors: Alex Jolly; Cameron Jolly; Kristin King; Jose Comino; Daniel Carrillo; Wayne Fong; Kenneth Green
Original assignee: Individual
Current assignee: Passy Muir Inc
Priority date: 2019-04-19
Filing date: 2020-04-20
Publication date: 2020-10-22
Also published as: US12220374B2; US20250009596A1; US12220373B2; US20250009597A1; US20240091098A1; US11229576B2; US20240091099A1; US20210322262A1; US20210322263A1; US20250009595A1; US11850205B2; US11413214B2; US20220378650A1; US11419784B2; US20210322261A1

Abstract

A laryngeal nerve exciting system includes a collar holding a bridge, or a neckband, pressing soft tissue nerve exciters against a patient's neck providing a source of vibrations to stimulate the laryngeal nerve through the larynx. At least one exciter, and preferably two exciters, provide vibrations at preferably 70 Hz to 110 Hz and sufficiently strong to penetrate to the laryngeal nerve. The exciters may be held by the collar circling the neck, or by the neck band partially circling the neck. The therapy system includes a Personal Digital Assistant (PDA) and software which wirelessly connects, monitors, and triggers the device. The system may be used to treat dysphagia, chronic cough, and spasmodic dysphonia.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims the priority of U.S. Provisional Patent Application Ser. No. 62/836,195 filed Apr. 19, 2019 which application is incorporated in its entirety herein by reference.

BACKGROUND OF THE INVENTION

The present invention relates to human tissue stimulation and in particular to noninvasive vibration on the neck overlying the larynx to excite the laryngeal nerve to augment or reestablish swallowing control during rehabilitation of patients with dysphagia, and to treat voice disorders affecting the function of the laryngeal system, such as spasmodic dysphonia, and to treat chronic cough.
Dysphagia is a major swallowing disorder that affects the central nervous system, and the peripheral nervous system, thereby weakening neuromuscular control and effectively reducing the ability to properly swallow. Dysphagia may occur at any time across the lifespan. This impairment has many potential causes, including but not limited to neurologic disorders, degenerative disease processes, and anatomical changes. Dysphagia is characterized by difficulty swallowing, impaired ability to protect the airway during swallowing (penetration and aspiration), and impaired ability to transport a bolus of food or liquid from the mouth to the stomach. These difficulties may contribute to a risk for respiratory complications (pneumonia), dehydration, malnutrition, and may restrict social eating. Because of these negative impacts, it also may significantly impact quality of life for an individual.
An occasional cough is normal in that it helps to clear irritants and secretions from the lungs; however, when a cough lasts longer than eight weeks in adults and begins to interfere with daily functions, such as sleep and bladder control, then it may be diagnosed as a chronic cough. In children, this diagnosis may occur after four weeks of coughing. Chronic cough occurs in the upper airway of the respiratory system, and the condition may be caused by co-morbidities, such as asthma, post-nasal drip, or reflux. However, the mechanism is unknown. The cough reflex may be impaired by a disease condition that weakens the cough which could lead to muscle weakness or paralysis, or it may be secondary to laryngeal nerve involvement.
Spasmodic dysphonia is a disorder that may occur with neurological disorders or disease processes that impact laryngeal function and muscles of the voice. This disorder of the laryngeal system causes the muscles involved in voicing to periodically spasm, triggering increased tension and a distortion of the voice. The spasms cause interruptions and breaks in the voice. Causes of spasmodic dysphonia are unknown but may relate to such processes as anxiety, infection, or direct injury to the larynx. It is more common in women and occurs most often between the ages of 30-50 years.
Any neurologic disease or process that impacts laryngeal function may negatively impact swallowing, voicing, and airway functions such as cough and throat clear, or any function that originates within or requires function of the laryngeal system. Various functions within the laryngeal system occur due to stimulation of the afferent pathways which transmit impulses to the brain and are then interpreted for communication with the efferent system for movement. Current treatment for an impairment or changes of laryngeal function that is caused by various neurological disorders or laryngeal injury are typically long-term behavioral therapy or invasive treatment with the injection of foreign materials or medications into the muscles, nerves, or tissues of the larynx. However, various disorders, such as dysphagia, chronic cough, and voicing disorders, may be improved by innervation of the afferent system within the larynx including the branches of the vagus nerve, such as the recurrent laryngeal, superior laryngeal, and pharyngeal branches, and vibration is known to relax muscles and to provide stimulation to tissues being innervated offering an alternative treatment.
U.S. Pat. No. 8,388,561 describes a vibrotactile stimulator having a band 101 worn around a patient's neck and including a vibrator 102 positionable over the larynx to provide stimulation generally centered on the patient's neck. The vibrator 102 is an electric motor spinning an offset weight. While the '561 patent provides a potential method for addressing dysphagia, there remains a need for improved dysphagia therapy devices.

BRIEF SUMMARY OF THE INVENTION

The present invention addresses the above and other needs by providing a vibrating laryngeal nerve exciting device which includes a collar holding a bridge, or a neckband, pressing soft tissue nerve exciters against a patient's neck providing a source of vibrations to stimulate the branches of the vagus nerve, such as the recurrent laryngeal, superior laryngeal, and pharyngeal branches. At least one exciter, and preferably two exciters, provide vibrations preferably adjustable between 30 Hz and 200 Hz and more preferably between 70 and 110 Hz and sufficiently strong to penetrate to the laryngeal nerve, for example, a pressure of 2-4 kpa or a vibration amplitude of 0.15 mm to 0.25 mm The exciters may be held by the collar circling the neck, or by the neck band partially circling the neck. The therapy system includes a Personal Digital Assistant (PDA) device and software which wirelessly connects, monitors, and triggers the device. The system may be used to treat dysphagia, chronic cough, and spasmodic dysphonia.
In accordance with one aspect of the invention, there is provided software (e.g., a smartphone application) which wirelessly connects and triggers the device, for example, through a Bluetooth® protocol. The software sets the frequency of the device, intensity, therapy time, vibration time, duration of rest period between vibration, and allows for patients to provide feedback about the therapy. A general state of health section allows the patient to diary how the patient is feeling before and after the therapy. The software allows clinicians to monitor the patient's progress. The clinician can see the device settings (frequency of the device, intensity, therapy time, vibration time, duration of rest period between vibration), number of uses, whether therapy was completed, and the patient's feedback diary.

BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING

The above and other aspects, features and advantages of the present invention will be more apparent from the following more particular description thereof, presented in conjunction with the following drawings wherein:

FIG. 1A shows a front view of a laryngeal nerve exciter according to the present invention.

FIG. 1B shows a top view of the laryngeal nerve exciter according to the present invention.

FIG. 1C shows a rear view of the laryngeal nerve exciter according to the present invention.

FIG. 2 shows an end effector of the laryngeal nerve exciter according to the present invention.

FIG. 3 shows a top view of a second embodiment of a laryngeal nerve exciter according to the present invention.

FIG. 4 shows a neckband laryngeal nerve exciter according to the present invention on a patent.

FIG. 5 shows a top view of the neckband laryngeal nerve exciter according to the present invention.

FIG. 6 shows a perspective view of the neckband laryngeal nerve exciter according to the present invention.

FIG. 7 shows a nerve exciter of the neckband laryngeal nerve exciter according to the present invention.

FIG. 8 shows an adhesive pad of the neckband laryngeal nerve exciter according to the present invention.

FIG. 9 shows a laryngeal nerve exciting system according to the present invention.

Corresponding reference characters indicate corresponding components throughout the several views of the drawings.

DETAILED DESCRIPTION OF THE INVENTION

The following description is of the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of describing one or more preferred embodiments of the invention. The scope of the invention should be determined with reference to the claims.
Where the terms “about” or “generally” are associated with an element of the invention, it is intended to describe a feature's appearance to the human eye or human perception, and not a precise measurement.
A front view of a laryngeal nerve exciter 10 according to the present invention is shown in FIG. 1 a, a top view of the laryngeal nerve exciter 10 is shown in FIG. 1B, and a rear view of the laryngeal nerve exciter 10 is shown in FIG. 1C. The laryngeal nerve exciter 10 includes a bridge 12, an exciter 14, effector sleeves 16, end effectors 18, strap slots 20, and a strap 22. The exciter 14 is preferably a solenoid or a voice coil, or any device capable of generating vibrations at various frequencies, for example, vibrations between 30 and 200 Hz and preferably between 70 and 110 HZ and sufficiently strong to reach the laryngeal nerve for example, a pressure of 2-4 kpa or a vibration amplitude of 0.15 mm to 0.25 mm.
The end effector 18 of the laryngeal nerve exciter 10 is shown in FIG. 2. A force sensor 24 resides under each end effector 18 and provides force information to allow adjusting the tightness of the strap 22.
A top view of a second embodiment of a laryngeal nerve exciter 30 is shown in FIG. 3. The laryngeal nerve exciter 30 includes end effectors 18 a held inside sleeves 16 a and springs (or a resilient material) 34 holding the end effectors 18 a against transducers 32. An adjust screw 36 presses the transducer 32 and end effector 18 a against the spring 34 allowing adjustment of the end effectors 18 a against the patient's neck without adjusting the strap 22. The transducers 32 may both vibrate the end effectors 18 a to stimulate the laryngeal nerve and may sense a patient's attempt to swallow, and may sense stimulation by the other end effector 18 a. The laryngeal nerve exciter 30 may include the force sensor 24 under the effector 16 a. In another embodiment, the end effectors 18 a may be fixedly attached to the moving part of the transducers 32 and no spring 34 is required.
FIG. 4 shows a neckband laryngeal nerve exciter (neckband trainer) 42 on a patient 40. The neckband trainer 42 does not press against the patient's throat providing greater comfort for the patient. Two exciters 44 are pressed against sides of the neck. The exciters 44 preferably receive up to 10 Watts (five Watts per exciter). The neckband trainer 42 provides pressure to the area where the exciters 44 contact the neck. The force of the exciters 44 against the neck is measured and an alarm is generated if the force exceeds a threshold.
FIG. 5 shows a top view of the neckband trainer 42 and FIG. 6 shows a perspective view of the neckband trainer 42. The neckband trainer 42 includes the exciters 44, a circuit 46, and battery compartments 48 and 50. The neckband trainer 42 includes a charging port for charging batteries and is adjustable for individual patients.
FIG. 7 shows a nerve exciter 44 of the neckband laryngeal nerve exciter.
FIG. 8 shows an adhesive pad 52 of the neckband trainer 42. The adhesive pad 52 comprises a top adhesive pad 54, a plastic snap 56, and a bottom adhesive pad 58. The exciter 44 snaps onto the adhesive pad 52 to retain the exciter 44 against the patient's neck.
A laryngeal nerve exciter system 60 is shown in FIG. 9. The system 60 utilizes a software Application (App) residing in a Personal Digital Assistant (PDA) 64 which triggers, and monitors the neckband trainer 42 through a Bluetooth® interface 62. The interface 62 may include frequency, intensity, therapy time, vibration time, duration of rest period between vibration, and allows for patients to provide feedback about the therapy.
The PDA 64 may communicate with a secure server 68 through the Internet or any other suitable connection including wireless or wired connections 66 providing signals include frequency, intensity, therapy time, vibration time, duration of rest period between vibration, clinician calibration, and allows for patients to provide feedback about the therapy.
The secure server 68 may communicate with a work station 72 over the Internet or any other suitable connection including wireless or wired connections 70 providing signals include frequency, intensity, therapy time, vibration time, duration of rest period between vibration, and clinician calibration, and allows for patients to provide feedback about the therapy to the clinician.
The App may set the frequency of the neckband trainer 42, intensity, therapy time, vibration time, duration of rest period between vibration, and allows for patients to provide feedback about the therapy. Measurements made by the neckband trainer 42 (e.g., force measured by the exciters) may be provided to the PDA 46 via the Bluetooth® connection. Further, the system 60 may allow clinicians to monitor the patient's progress. The clinician will be able to see the device settings, frequency of the device, intensity, therapy time, vibration time, duration of rest period between vibration, number of uses, whether therapy was completed, and the patient feedback. A general state of health section for the patient may be provided to indicate how the patient is feeling before and after the therapy. The PDA 64 may be a smart phone.
While the invention herein disclosed has been described by means of specific embodiments and applications thereof, numerous modifications and variations could be made thereto by those skilled in the art without departing from the scope of the invention set forth in the claims.

Claims

I claim:

1. A laryngeal nerve exciter system, compromising:

a neckband configured to reside at least partially around a patient neck;

a pair of soft tissue nerve effectors held by the neckband and configured to reside against the patient neck and conduct vibrations to the patient neck; and

wherein the neckband is positionable to locate the effectors simulate a laryngeal nerve.

2. The laryngeal nerve exciter system of claim 1, wherein the neckband is positionable to locate the effectors simulate the laryngeal nerve through a larynx.

3. The laryngeal nerve exciter system of claim 1, wherein:

the nerve effectors are attached to a bridge; and

the neck band draws the bridge towards the patient neck.

4. The laryngeal nerve exciter system of claim 1, wherein:

the nerve effectors are attached to a bridge; and

the neck band draws the nerve effectors towards the patient neck.

5. The laryngeal nerve exciter system of claim 4, wherein pressure transducers reside under the nerve effectors.

6. The laryngeal nerve exciter system of claim 3, wherein at least one exciter is attached to the bridge to vibrate the bridge.

7. The laryngeal nerve exciter system of claim 3, wherein one exciter is attached to the bridge between the nerve effectors.

8. The laryngeal nerve exciter system of claim 7, wherein the exciter is a voice coil.

9. The laryngeal nerve exciter system of claim 3, wherein an exciter resides under each of the nerve effectors to vibrate each nerve effector.

10. The laryngeal nerve exciter system of claim 3, wherein:

each nerve effector is biased towards the bridge by a resilient material or a spring; and

an exciter resides under each nerve effector to vibrate each nerve effector.

11. The laryngeal nerve exciter system of claim 10, wherein a pressure sensor resides between each exciter and each nerve effector.

12. The laryngeal nerve exciter system of claim 10, wherein a pressure adjustor resides each exciter and each nerve effector.

13. The laryngeal nerve exciter system of claim 1, wherein:

the neck band is configured to wrap around behind the patient neck and has free ends at an open front;

the nerve effectors are attached to the neck band at the free ends; and

the neck band urges that nerve effectors against the patent neck.

14. The laryngeal nerve exciter system of claim 1, wherein:

the neck band includes a battery compartment electrically connected to a programmable circuit;

exciters are attached to the neck band to vibrate the nerve effectors; and

the circuit is electrically connected to the exciters.

15. The laryngeal nerve exciter system of claim 14, wherein:

the circuit communicates with a Personal Digital Assistant (PDA); and

the PDA allows control of at least one parameter selected from the group consisting of: frequency; intensity; therapy time; vibration time; and duration of rest period between vibration, and allows for patients to provide patient feedback about results of therapy.

16. The laryngeal nerve exciter system of claim 15, wherein the PDA is configured to communicate with a clinician work station to provide the at least one parameter, and the patent feedback.

17. The laryngeal nerve exciter system of claim 15, wherein the exciter is configured to vibrate the nerve effectors at between 30 and 200 Hz and sufficiently strong to reach the laryngeal nerve.

18. The laryngeal nerve exciter system of claim 17, wherein the exciter is configured to vibrate the nerve effectors at between 70 and 110 Hz and a pressure of 2-4 kpa or a vibration amplitude of 0.15 mm to 0.25 mm.

19. A laryngeal nerve exciter system, compromising:

a pair of soft tissue nerve effectors attached to a bridge;

a neckband attached to the bridge and positionable to locate the nerve effectors against a patient neck;

the neck band configured to draw the bridge towards the patient neck;

pressure transducers residing under the nerve effectors;

a voice coil attached to the bridge between the nerve effectors;

a programmable circuit electrically connected to the voice coil configured to vibrate the nerve effectors at between 70 and 110 Hz sufficiently strong to conduct vibrations to the patient neck to simulate the laryngeal nerve through a larynx and reach the laryngeal nerve; and

batteries electrically connected to the circuit.

20. A laryngeal nerve exciter system, compromising:

the nerve effectors are attached to the neck band at the free ends; and

the neck band urges that nerve effectors against the patent neck a voice coil attached to the bridge between the nerve effectors;

a programmable circuit electrically connected to the voice coil configured to vibrate the nerve effectors at between 70 and 110 Hz and a pressure of 2-4 kpa or a vibration amplitude of 0.15 mm to 0.25 mm;

batteries electrically connected to the circuit;

the circuit configured to communicate with a Personal Digital Assistant (PDA);

the PDA configured to control of at least one parameter selected from the group consisting of: frequency; intensity; therapy time; vibration time; and duration of rest period between vibration, and allowing patient feedback about results of patient therapy; and

the PDA further configured to communicate with a clinician work station to provide the at least one parameter, and the patent feedback to the clinician work station